Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(3.01)
# 1,397
Out of 4,911 analysts
12
Total ratings
72.73%
Success rate
40.31%
Average return
Main Sectors:
Stocks Rated by Jeff Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMTC NeuroOne Medical Technologies | Initiates: Buy | $1.45 | $0.90 | +61.78% | 1 | May 5, 2025 | |
| CBLL CeriBell | Initiates: Buy | $32 | $15.12 | +111.64% | 1 | Apr 4, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $31 | $14.74 | +110.38% | 1 | Feb 20, 2025 | |
| LGCY Legacy Education | Maintains: Buy | $9.1 → $11 | $11.46 | -5.76% | 2 | Feb 14, 2025 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.40 | - | 1 | Nov 15, 2024 | |
| SNOA Sonoma Pharmaceuticals | Initiates: Buy | $65 | $3.44 | +1,789.53% | 1 | Sep 5, 2023 | |
| DKNG DraftKings | Initiates: Overweight | $52 | $44.91 | +15.79% | 1 | Jul 1, 2020 | |
| SE Sea Limited | Initiates: Overweight | $130 | $158.09 | -17.77% | 1 | Jul 1, 2020 | |
| TTWO Take-Two Interactive Software | Maintains: Equal-Weight | $110 → $130 | $223.24 | -41.77% | 3 | May 21, 2020 |
NeuroOne Medical Technologies
May 5, 2025
Initiates: Buy
Price Target: $1.45
Current: $0.90
Upside: +61.78%
CeriBell
Apr 4, 2025
Initiates: Buy
Price Target: $32
Current: $15.12
Upside: +111.64%
Beta Bionics
Feb 20, 2025
Initiates: Buy
Price Target: $31
Current: $14.74
Upside: +110.38%
Legacy Education
Feb 14, 2025
Maintains: Buy
Price Target: $9.1 → $11
Current: $11.46
Upside: -5.76%
Bionano Genomics
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.40
Upside: -
Sonoma Pharmaceuticals
Sep 5, 2023
Initiates: Buy
Price Target: $65
Current: $3.44
Upside: +1,789.53%
DraftKings
Jul 1, 2020
Initiates: Overweight
Price Target: $52
Current: $44.91
Upside: +15.79%
Sea Limited
Jul 1, 2020
Initiates: Overweight
Price Target: $130
Current: $158.09
Upside: -17.77%
Take-Two Interactive Software
May 21, 2020
Maintains: Equal-Weight
Price Target: $110 → $130
Current: $223.24
Upside: -41.77%